Yihua Wang

Dr. Yihua Wang

Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton SO17 1BJ, UK
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
XWXiaojun Wu
Xiaojun Wu
XLXiaofan Liu
Xiaofan Liu
YZYilu Zhou
Yilu Zhou
HYHongying Yu
Hongying Yu
RLRuiyun Li
Ruiyun Li
Yihua WangYihua Wang
Yihua Wang

1 June 2007 in Cell
Verified
Journal Article
Closed access
SGSurbhi Gupta
Surbhi Gupta
ARAntoine R. Ramjaun
Antoine R. Ramjaun
PHPaula Haiko
Paula Haiko
Yihua WangYihua Wang
Yihua Wang
PWPatricia H. Warne
Patricia H. Warne
JDJulian Downward
Julian Downward

1 May 2020 in Chest
Verified
Journal Article
Open access
GSGaohong Sheng
Gaohong Sheng
PCPeng Chen
Peng Chen
YWYanqiu Wei
Yanqiu Wei
HYHuihui Yue
Huihui Yue
JCJiaojiao Chu
Jiaojiao Chu
HZHuilan Zhang
Huilan Zhang
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic lung disease with a poor prognosis. Although many factors have been identified that possibly trigger or aggravate IPF, such as viral infection, the exact cause of IPF remains unclear. Until now, there has been no systematic review to assess the role of viral infection in IPF quantitatively. This meta-analysis aims to present a collective view on the relationship between viral infection and IPF. We searched studies reporting the effect of viral infection on IPF in the PubMed, Embase, Cochrane Library, Web of Science, and Wiley Online Library databases. We calculated ORs with 95% CIs to assess the risk of virus in IPF. We also estimated statistical heterogeneity by using I2 and Cochran Q tests and publication bias by using the funnel plot, Begg test, Egger test, and trim-and-fill methods. Regression, sensitivity, and subgroup analyses were performed to assess the effects of confounding factors, such as sex and age. We analyzed 20 case-control studies from 10 countries with 1,287 participants. The pooled OR of all viruses indicated that viral infection could increase the risk of IPF significantly (OR, 3.48; 95% CI, 1.61-7.52; P = .001), but not that of exacerbation of IPF (OR, 0.99; 95% CI, 0.47-2.12; P = .988). All analyzed viruses, including Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8), were associated with a significant elevation in the risk of IPF, except human herpesvirus 6 (HHV-6). The presence of persistent or chronic, but not acute, viral infections, including EBV, CMV, HHV-7, and HHV-8, significantly increases the risk of developing IPF, but not exacerbation of IPF. These findings imply that viral infection could be a potential risk factor for IPF.

1 July 2020 in Journal of Infection
Verified
Journal Article
Open access
XLXiaofan Liu
Xiaofan Liu
HZHong Zhou
Hong Zhou
YZYilu Zhou
Yilu Zhou
XWXiaojun Wu
Xiaojun Wu
YZYang Zhao
Yang Zhao
Yihua WangYihua Wang
Yihua Wang

15 May 2019 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
PLPiao Li
Piao Li
THTingting Huang
Tingting Huang
QZQi Zou
Qi Zou
DLDian Liu
Dian Liu
Yihua WangYihua Wang
Yihua Wang
HQHong Qiu
Hong Qiu
Although multidisciplinary treatment is widely applied in colorectal cancer (CRC), the prognosis of patients with advanced CRC remains poor. Immunotherapy blocking of programmed cell death ligand 1 (PD-L1) is a promising approach. Binding of the transmembrane protein PD-L1 expressed by tumor cells or tumor microenvironment cells to its receptor programmed cell death 1 (PD-1) induces immunosuppressive signals and reduces the proliferation of T cells, which is an important mechanism of tumor immune escape and a key issue in immunotherapy. However, the regulation of PD-L1 expression is poorly understood in CRC. Fibroblast growth factor (FGF) receptor (FGFR) 2 causes the tyrosine kinase domains to initiate a cascade of intracellular signals by binding to FGFs and dimerization (pairing of receptors), which is involved in tumorigenesis and progression. In this study, we showed that PD-L1 and FGFR2 were frequently overexpressed in CRC, and FGFR2 expression was significantly associated with lymph node metastasis, clinical stage, and poor survival. In the current study, PD-L1 expression was positively correlated with FGFR2 expression in CRC. Tumor-derived–activated FGFR2 induced PD-L1 expression via the JAK/STAT3 signaling pathway in human CRC cells (SW480 and NCI-H716), which induced the apoptosis of Jurkat T cells. FGFR2 also promoted the expression of PD-L1 in a xenograft mouse model of CRC. The results of our study reveal a novel mechanism of PD-L1 expression in CRC, thus providing a theoretical basis for reversing the immune tolerance of FGFR2 overexpression in CRC.

7 August 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
CHCharlotte Hill
Charlotte Hill
JLJuanjuan Li
Juanjuan Li
DLDian Liu
Dian Liu
FCFranco Conforti
Franco Conforti
CBChristopher J. Brereton
Christopher J. Brereton
Yihua WangYihua Wang
Yihua Wang
Idiopathic pulmonary fibrosis (IPF), the prototypic progressive fibrotic interstitial lung disease, is thought to be a consequence of repetitive micro-injuries to an ageing, susceptible alveolar epithelium. Ageing is a risk factor for IPF and incidence has been demonstrated to increase with age. Decreased (macro)autophagy with age has been reported extensively in a variety of systems and diseases, including IPF. However, it is undetermined whether the role of faulty autophagy is causal or coincidental in the context of IPF. Here, we report that in alveolar epithelial cells inhibition of autophagy promotes epithelial–mesenchymal transition (EMT), a process implicated in embryonic development, wound healing, cancer metastasis and fibrosis. We further demonstrate that this is attained, at least in part, by increased p62/SQSTM1 expression that promotes p65/RELA mediated-transactivation of an EMT transcription factor, Snail2 (SNAI2), which not only controls EMT but also regulates the production of locally acting profibrogenic mediators. Our data suggest that reduced autophagy induces EMT of alveolar epithelial cells and can contribute to fibrosis via aberrant epithelial–fibroblast crosstalk.